HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

Hepatitis C virus (HCV) cure after all-oral direct-acting antiviral (DAA) therapy greatly improves the liver and immune system. We aimed to assess the impact of this HCV clearance on immune system-related markers in plasma and the gene expression profile in human immunodeficiency virus (HIV)/HCV-coi...

Description complète

Détails bibliographiques
Auteurs principaux: Óscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, Juan González-García, Sergio Salgüero, Daniel Sepúlveda-Crespo, Cristina Díez, Víctor Hontañón, Luis Ibañez-Samaniego, Leire Pérez-Latorre, Amanda Fernández-Rodríguez, María Ángeles Jiménez-Sousa, Salvador Resino
Format: Article
Langue:English
Publié: Frontiers Media S.A. 2021-08-01
Collection:Frontiers in Immunology
Sujets:
HIV/HCV coinfection
immune system
cirrhosis
DAA therapy
plasma biomarkers
PBMCs
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fimmu.2021.723196/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.723196/full

Documents similaires